Clinical trials
Trigeminal Neuralgia trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Not yet recruiting | 9 |
| Unknown status | 7 |
| Recruiting | 6 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tiantan Hospital | 4 |
| Assiut University | 3 |
| Alexandria University | 2 |
| Diskapi Teaching and Research Hospital | 2 |
| Sohag University | 2 |
| University of Florida | 2 |
| Yuanyuan Wu | 2 |
| Zagazig University | 2 |
| Abbasi Shaheed Hospital | 1 |
| Ankara City Hospital Bilkent | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Trigeminal Neuralgia | 54 |
| Neuralgia | 6 |
| Facial Pain | 3 |
| Headache Disorders | 2 |
| Neuralgia, Postherpetic | 2 |
| Pain | 2 |
| Agnosia | 1 |
| Aneurysm | 1 |
| Bites and Stings | 1 |
| Brain Diseases | 1 |
Trials
Showing 26 to 50 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.